Vytrus Biotech (private company)

See something wrong or missing? Let us know
Offices:Barcelona
Business model:B2B

Vytrus Biotech was foundedx as Phyture Biotech, a spin-off company of the Faculty of Pharmacy at the Universitat de Barcelona, from a research group with more than 40 years of experience in the technology of plant cell cultures. On 2011 we launched the company's first cosmetic ingredient, and in 2013, the first medical device, based in the plant cell cultures technology, and pioneer in the Spanish market.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.53M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Vytrus Biotech

Name Criteria
Denmark Biograil
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 5M - 10M USD
France Cell-Easy
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Sweden Gradientech
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom iLoF
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Sweden Monocl
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Denmark Octarine Bio
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Finland Rappta Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Austria Sarcura
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 5M - 10M USD
Ireland Solvotrin Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Spain Veritas Intercontinental
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top